India Can Weather 15% Tariffs: Helios Capital’s Samir Arora Dismisses Trade Fears

Samir Arora, the veteran founder of Helios Capital, has injected a dose of pragmatism into the global trade debate, asserting that a 15% tariff regime is not a cause for alarm for the Indian economy. As global markets brace for a shift toward more protectionist trade policies—particularly from the United States under a renewed focus on universal baseline tariffs—Arora’s stance highlights a growing consensus among institutional investors that India’s structural strengths may insulate it from the worst effects of a global trade war.

The 15% figure is significant, aligning with proposed universal baseline tariffs discussed in recent geopolitical cycles. While such a move would typically trigger market volatility, Arora’s perspective suggests that India’s relative isolation from global supply chain shocks provides a unique buffer. Unlike the export-led models of East Asian economies, India’s growth trajectory is heavily driven by domestic consumption, which accounts for roughly 60% of its GDP. This internal engine allows the Indian economy to maintain momentum even when external trade conditions tighten.

“

Samir Arora, the veteran founder of Helios Capital, has injected a dose of pragmatism into the global trade debate, asserting that a 15% tariff regime is not a cause for alarm for the Indian economy.

A critical component of Arora's thesis is the relative positioning of India versus its primary trade competitors, most notably China. In a scenario where the U.S. imposes a 15% baseline tariff on most nations but targets China with significantly higher levies—potentially exceeding 60%—India emerges as a relative winner. This disparity accelerates the 'China Plus One' strategy, where multinational corporations seek to diversify their manufacturing bases. Even with a 15% tariff, India remains a highly competitive alternative for global firms seeking to de-risk their supply chains while maintaining access to a massive and growing labor pool.

However, the impact will not be entirely uniform across all sectors of the Indian economy. India’s IT services sector, which derives a majority of its revenue from U.S.-based clients, could face margin pressure if those clients seek to offset their own tariff-related costs by renegotiating service contracts. Similarly, the pharmaceutical sector, which provides a significant portion of generic medications to the American market, may see increased regulatory and cost scrutiny. Despite these headwinds, the broader manufacturing sector—spanning electronics, specialty chemicals, and automotive components—is expected to see a net benefit as global procurement shifts toward 'friend-shoring' partners like India.

From an investment perspective, Arora’s comments reflect a 'glass half full' approach that is increasingly common among India-focused fund managers. By framing 15% tariffs as a manageable hurdle rather than an existential threat, Helios Capital is signaling to global investors that the Indian equity story remains intact. The focus remains on corporate earnings growth, which has historically shown resilience in the face of currency fluctuations and global trade tensions. Investors are encouraged to look past the initial headline shock of tariff announcements and focus on the underlying shift in global trade architecture that favors stable, democratic manufacturing hubs.

Looking ahead, the market will be watching for the official response from New Delhi. While Arora is optimistic, the Indian government may still pursue reciprocal trade measures or seek specific exemptions for critical industries. The ability of Indian policymakers to navigate these bilateral negotiations will be the next major catalyst for market sentiment. For now, the message from one of India's most prominent fund managers is clear: the country's economic fundamentals are robust enough to withstand the incoming waves of global protectionism.